Make Better Decisions - Finding and Evaluating Generic and Branded Drug Market Entry Opportunities

Get the Book: Make Better Decisions

Finding and Evaluating Generic and Branded Drug Market Entry Opportunities

PDF eBook: Just $10 Get Print Book on Amazon

Serving leading biopharmaceutical companies globally:

Harvard Business School
Mallinckrodt
Johnson and Johnson
Dow
Moodys
Colorcon

Last Updated: December 8, 2019

DrugPatentWatch Database Preview

Drug Price Trends for NDC 50991-0492

Join the DrugPatentWatch Referral Program
Get access to a free drug patent landscape report or a free one-month subscription

« Back to Dashboard

Average Pharmacy Cost for 50991-0492

Drug Name NDC Price/Unit ($) Unit Date
POLYTUSSIN DM SYRUP 50991-0492-16 0.05517 ML 2019-11-20
POLYTUSSIN DM SYRUP 50991-0492-16 0.05520 ML 2019-10-23
POLYTUSSIN DM SYRUP 50991-0492-16 0.05512 ML 2019-09-18
POLYTUSSIN DM SYRUP 50991-0492-16 0.05748 ML 2019-08-21
POLYTUSSIN DM SYRUP 50991-0492-16 0.05339 ML 2019-07-17
POLYTUSSIN DM SYRUP 50991-0492-16 0.05441 ML 2019-05-22
POLYTUSSIN DM SYRUP 50991-0492-16 0.05323 ML 2019-04-17
>Drug Name >NDC >Price/Unit ($) >Unit >Date

Subscribe to access the full database, or Start Trial

Best Wholesale Price for NDC 50991-0492

These are wholesale prices available to the US Federal Government which, by law, must be the best prices available under comparable terms and conditions
Drug Name Vendor NDC Count Price ($) Price/Unit ($) Dates Price Type
>Drug Name >Vendor >NDC >Count >Price ($) >Price/Unit ($) >Dates >Price Type

Subscribe to access the full database, or Start Trial

Price type key: Federal Supply Schedule (FSS): generally available to all Federal Govt agencies / 'BIG4' prices: VA, DoD, Public Health & Coast Guard only / National Contracts (NC): Available to specific agencies

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Dow
Johnson and Johnson
Mallinckrodt
AstraZeneca
McKesson
Boehringer Ingelheim

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

 
Copyright 2002-2019 thinkBiotech LLC
ISSN: 2162-2639
Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions
Site Map
DrugPatentWatch Alternatives
LOE / Generic Entry Opportunies 2019 - 2020
 NCE-1 Patent Challenge Dates 2019 - 2020
Preferred Citation:

Friedman, Yali. "DrugPatentWatch" DrugPatentWatch, thinkBiotech, 2019, www.DrugPatentWatch.com.

Links

Follow DrugPatentWatch:

DrugPatentWatch reviews